Viatris Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2020-11-16
- Employees
- 38K
- Market Cap
- $13.9B
- Website
- http://www.viatris.com
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Viatris Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06471088
- Locations
- 🇰🇷
Viatris, Seoul, Korea, Republic of
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Phase 1
Not yet recruiting
- Conditions
- Bioequivalence Study
- Interventions
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Viatris Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06273254
- Locations
- 🇹🇭
Medica Innova Co Ltd, Bangkok, Thailand
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Phase 1
Not yet recruiting
- Conditions
- Chronic Heart Failure
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Viatris Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06266988
News
Heron Therapeutics Settles Patent Litigation with Mylan for CINVANTI and APONVIE
Heron Therapeutics has reached a settlement agreement with Mylan Pharmaceuticals to resolve ongoing patent litigations related to CINVANTI and APONVIE injectable emulsions.
FDA Panel Rejects Lexicon's Zynquista for Type 1 Diabetes
An FDA advisory committee voted against approving Lexicon's Zynquista (sotagliflozin) as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD).